Company intelligence / Profile preview

Therapure Biopharma Inc.

Mississauga, Ontario, Canadatherapurebio.com ↗

Ownership: Private
Employees: ~300
Development stage: Other

Overview

Therapure had several programs in development, including TBI-302 which received FDA approval to proceed with Phase 1 clinical trials for liver cancer in 2015. The company was later acquired and split into different entities.

Therapeutic areas: OncologyImmunologyInfectious DiseasesHematology
Modalities: Therapeutic proteinsPlasma-derived therapeutics
Industry: Biotech

Partnerships

BioVectra Inc.LFB Technologies3SBio Inc.CITICPE

Beyond the preview

Go deeper on Therapure Biopharma Inc..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Therapure Biopharma Inc..